Molecular interaction between human tumor marker protein p150, the largest subunit of eIF3, and intermediate filament protein K7

The human tumor marker protein p150 was identified as the largest subunit of eukaryotic translation initiation factor 3 (eIF3) (also known as p170/p180). Its expression level is not only upregulated in many transformed cell lines, but also in several human cancers including breast, cervical, esophageal, and stomach carcinomas. The function of p150 in cancer and initiation of translation are not well understood. Using the yeast two‐hybrid genetic screen, we found that a portion of p150 interacts with hPrt1, another subunit of eIF3, and cytokeratin 7, an intermediate filament protein. The interactions between p150 and hPrt1, and between p150 and cytokeratin 7 were verified both in vivo and in vitro. The interaction site for hPrt1 was mapped to the carboxyl half of the coiled‐coil region of the p150 protein between amino acids 664–835. The expression of hPrt1 was clearly upregulated in cancer tissue, similarly to that of p150. By contrast, no substantial difference in the expression level of cytokeratin 7 was observed between cancer and normal breast tissue, suggesting that cytokeratin 7 expression is not co‐regulated with p150. Taken together, our studies suggest a new role for p150 in translation initiation, possibly by acting as an adapter molecule between the translation initiation apparatus and the cytoskeleton structure in the cell. J. Cell. Biochem. 80:483–490, 2001. © 2001 Wiley‐Liss, Inc.

[1]  A. Lupas,et al.  Predicting coiled coils from protein sequences , 1991, Science.

[2]  J. Hershey,et al.  Translational initiation factor and ribosome association with the cytoskeletal framework fraction from HeLa cells , 1984, Cell.

[3]  J. Segall,et al.  Elongation factor-1 alpha is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma. , 1996, Journal of cell science.

[4]  N. Marceau,et al.  Epidermal growth factor-induced selective phosphorylation of cultured rat hepatocyte 55-kD cytokeratin before filament reorganization and DNA synthesis , 1989, The Journal of cell biology.

[5]  B. Erni.  Initiation of mammalian protein biosynthesis , 1976 .

[6]  W. Merrick,et al.  Identification of cDNA Clones for the Large Subunit of Eukaryotic Translation Initiation Factor 3 , 1997, The Journal of Biological Chemistry.

[7]  L. Hartwell,et al.  A mutant of yeast apparently defective in the initiation of protein synthesis. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[8]  N. Sonenberg,et al.  The Human Homologue of the Yeast Prt1 Protein Is an Integral Part of the Eukaryotic Initiation Factor 3 Complex and Interacts with p170* , 1997, The Journal of Biological Chemistry.

[9]  R. Singer,et al.  mRNA and cytoskeletal filaments. , 1997, Current opinion in cell biology.

[10]  R. Goldman,et al.  Intermediate filaments and cytoplasmic networking: new connections and more functions. , 1997, Current opinion in cell biology.

[11]  Jason R. Swedlow,et al.  Actin-dependent localization of an RNA encoding a cell-fate determinant in yeast , 1997, Nature.

[12]  J. Torhorst,et al.  Expression of p150 in cervical neoplasia and its potential value in predicting survival , 1998, Cancer.

[13]  M. Burger,et al.  p150 expression and its prognostic value in squamous‐cell carcinoma of the esophagus , 1999, International journal of cancer.

[14]  H. Vornlocher,et al.  Characterization of cDNAs Encoding the p44 and p35 Subunits of Human Translation Initiation Factor eIF3* , 1998, The Journal of Biological Chemistry.

[15]  G C Johnston,et al.  Molecular characterization of the yeast PRT1 gene in which mutations affect translation initiation and regulation of cell proliferation. , 1987, The Journal of biological chemistry.

[16]  T. Fukuchi-Shimogori,et al.  Malignant transformation by overproduction of translation initiation factor eIF4G. , 1997, Cancer research.

[17]  Robert H. Singer,et al.  The cytoskeleton and mRNA localization , 1992, Current Biology.

[18]  E. Fuchs,et al.  Isolation, sequence, and differential expression of a human K7 gene in simple epithelial cells , 1988, The Journal of cell biology.

[19]  A. Lupas.  Coiled coils: new structures and new functions. , 1996, Trends in biochemical sciences.

[20]  L. Valášek,et al.  Rpg1, the Saccharomyces cerevisiae Homologue of the Largest Subunit of Mammalian Translation Initiation Factor 3, Is Required for Translational Activity* , 1998, The Journal of Biological Chemistry.

[21]  R. Benne,et al.  The mechanism of action of protein synthesis initiation factors from rabbit reticulocytes. , 1978, The Journal of biological chemistry.

[22]  G. Dreyfuss,et al.  Messenger RNA is translated when associated with the cytoskeletal framework in normal and VSV-infected HeLa cells , 1981, Cell.

[23]  K. Porkka,et al.  Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. , 1999, The American journal of pathology.

[24]  G. Sagnella.  KINCALC: by S. W. Orchard, Elsevier-BIOSOFT, 1984. $30.00/£18.00 , 1985 .

[25]  N. Sonenberg,et al.  Abrogation of translation initiation factor eIF‐2 phosphorylation causes malignant transformation of NIH 3T3 cells. , 1995, The EMBO journal.

[26]  A. Hinnebusch,et al.  Complex Formation by All Five Homologues of Mammalian Translation Initiation Factor 3 Subunits from Yeast Saccharomyces cerevisiae * , 1998, The Journal of Biological Chemistry.

[27]  F. Bachmann,et al.  Cloning of a novel protein overexpressed in human mammary carcinoma. , 1997, Cancer research.

[28]  M. Inagaki,et al.  Phosphorylation of keratin intermediate filaments by protein kinase C, by calmodulin-dependent protein kinase and by cAMP-dependent protein kinase. , 1991, European journal of biochemistry.

[29]  Robert H. Singer,et al.  The cytoskeleton and mRNA localization. , 1992 .

[30]  J. Chaudhuri,et al.  Biochemical Characterization of Mammalian Translation Initiation Factor 3 (eIF3) , 1997, The Journal of Biological Chemistry.

[31]  J. Hershey,et al.  2 The Pathway and Mechanism of Eukaryotic Protein Synthesis , 1996 .

[32]  N. Sonenberg,et al.  A region rich in aspartic acid, arginine, tyrosine, and glycine (DRYG) mediates eukaryotic initiation factor 4B (eIF4B) self-association and interaction with eIF3 , 1996, Molecular and cellular biology.

[33]  R. Rhoads,et al.  Mapping of Functional Domains in Eukaryotic Protein Synthesis Initiation Factor 4G (eIF4G) with Picornaviral Proteases , 1995, The Journal of Biological Chemistry.

[34]  H. Trachsel,et al.  Association of a Mr 50,000 cap-binding protein with the cytoskeleton in baby hamster kidney cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[35]  H. Vornlocher,et al.  A 110-Kilodalton Subunit of Translation Initiation Factor eIF3 and an Associated 135-kilodalton Protein Are Encoded by theSaccharomyces cerevisiae TIF32 and TIF31Genes* , 1999, The Journal of Biological Chemistry.

[36]  H. Trachsel,et al.  Initiation of mammalian protein synthesis. The multiple functions of the initiation factor eIF-3. , 1979, Biochimica et biophysica acta.

[37]  N. Gupta,et al.  New Insights into an Old Problem: Ternary Complex (Met-tRNAf·eIF-2 ·GTP) Formation in Animal Cells , 1990 .

[38]  R. Lenk,et al.  A cytoskeletal structure with associated polyribosomes obtained from HeLa cells , 1977, Cell.